Mynd Healthcare

Library / regulatory-reference

Turkiye: Turkish Medicines and Medical Devices Agency (TITCK)

Audience: administrators-policy, researchers-scientists ยท Review state: published

The national authority

The Turkish Medicines and Medical Devices Agency, known by its Turkish initials TITCK, is Turkiye's national regulator for medicines, medical devices, cosmetics and related health products, operating under the Ministry of Health.

Turkiye sits at the junction of European and regional markets, and the agency's framework is closely aligned with the European medicines acquis, reflecting the country's customs union with the European Union and its long-standing candidacy track.

How products enter the market

Medicines require a marketing authorization granted after evaluation of quality, safety and efficacy, with documentation expectations closely tracking European standards. Pricing and reimbursement involve separate state processes, which makes market entry a multi-step exercise beyond the authorization itself.

Medical devices follow European-aligned classification and conformity rules, and the agency maintains national registration databases for devices and cosmetics alongside its medicines register.

Regional and international role

TITCK participates in international regulatory cooperation networks and its inspection and laboratory capacity is among the strongest in its region. Turkish pharmaceutical manufacturing is a major export sector, which gives the agency's good-manufacturing-practice inspections weight in supply chains reaching well beyond the country.

The agency has been an active participant in reliance-oriented work-sharing with European and regional partners.

Using this profile

TITCK publishes registers, guidance and announcements in Turkish through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.

For cross-country comparison: TITCK illustrates the EU-aligned regulator outside the EU, running European-pattern evaluation and device rules while operating its own national pricing and market processes.

Limitations

Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.